scorecardresearch
Add as a preferred source on Google
Tuesday, February 24, 2026
TopicPharmaceutical companies

Topic: Pharmaceutical companies

Health ministry eases drug trial rules. Test licences scrapped, CDSCO approval timelines cut by half

Under earlier rules, drugmakers had to get a test licence from CDSCO to manufacture small quantities of drugs for research, examination or analysis.

Top pharma alliance refutes ‘ill-researched’ US study linking Indian generics to higher adverse events

Indian Pharmaceutical Alliance says the study relies on FDA Adverse Event Reporting System data, which captures link between drugs & adverse events, but does not prove causation.

Indian pharmas improved USFDA compliance, but cases of contamination grew 2014-2024—IPA report

The report, released at Global Pharmaceutical Quality Summit in Mumbai, draws comparison of incidences of ‘official action indicated' after USFDA inspections a decade apart.

How Indian pharma firms are creating a drug crisis in West Africa & the rural road ‘revolution’

Global media also looks at the contest between US & Russia to sell fighter jets to India.

Govt relents, relaxes GMP adoption deadline for small, medium pharmas after RSS-backed body weighs in

The proposed extension for drugmakers in adopting Schedule M of Drugs and Cosmetics Act and Rules comes mainly at the behest of RSS-backed Laghu Udyog Bharti, it is learnt.

24 mega-seller drugs set to lose patents in US, big opportunity for Indian drugmakers — govt report

Patent expiry would mean that drugmakers will be able to launch generic versions of the blockbuster drugs, which are typically priced up to 90 percent lower than their innovator drug.

Import alerts, warning letters, drug recalls — why ‘pharmacy to the world’ is facing US FDA heat

New Delhi: On 18 April, Mumbai-headquartered Marksans Pharma, a drugmaker that supplies generic drugs in over 50 countries around the world, received form 483,...

Indian pharma market can more than treble by 2030, says industry report, urges focus on quality

Report by Organisation of Pharmaceutical Producers of India and Ernst & Young says growth could be propelled by expansion in the domestic market, spurred by India's economic growth.

2 cough syrups found ‘contaminated’, regulator launches probe into Gujarat drugmaker

CDSCO says two cough syrups manufactured by Ankleshwar-based Norris Pharma were found to contain Ethylene Glycol (EG) & Diethylene Glycol (DEG) beyond acceptable limits.

Patients’ groups oppose changes to patent rules, say could hinder access to affordable medicines

The groups say Draft Patents (Amendment) Rules could make it harder to challenge patent applications, impede process of obtaining compulsory licences & effect transparency in system.

On Camera

Where does the law stand on Himanta Biswa Sarma’s video of ‘shooting’ Muslims?

Assam CM Himanta Biswa Sarma's Hindu-Muslim polarisation is clearly done to maximise the odds of winning. But an important legal question is: does it expose him to legal liability?

FY23 chosen as new base for India’s GDP as it was 1st ‘normal economic year’ in a while—MoSPI secy

FY 2022-23 was the first normal economic year in recent years, said Saurabh Garg, Secretary of the Ministry of Statistics and Programme Implementation, in an interview with ThePrint.

IAF’s Tejas fleet undergoes ‘maintenance check’, decision on airframe yet to be taken

The 7 February incident involving Tejas aircraft caused severe damage to its frame. IAF and HAL are working together as part of the Board of Inquiry (BoI) to probe the incident.

No country is ever fully sovereign. Cold War era taught India its real meaning

India’s fraught neighbourhood places multiple constraints on its strategic choices. It leaves no time to take a deep breath, lean back and reset.